Patient reported improvement in dyspnea and physical inactivity with Budesonide/Glycopyrronium/Formoterol (BGF): AIR-FORCE*study
Year: 2025
Type: conference-abstract
Source: European Respiratory Journal
Authors: Saiprasad Patil, Divya Bhojwani, Deependra Kumar Rai, Hanmant Barkate, Sagar Bhagat
Institution: Glenmark Pharmaceuticals (India)
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4416638075
